UNSPSC 51284715: Tiamulin fumarate

This classification denotes an antibiotic with the molecular formula C28H47NO4S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ION1Q02ZCX, chemically known as acetic acid, ((2-(diethylamino)ethyl)thio)-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3-alpha,9-propano-3-alpha-h-cyclopentacycloocten-8-yl ester, (e)-2-butenedioate (1:1) (salt) but more generally known as tiamulin fumarate, which bears US NIH Compound Identifier 6434500.

UNSPSC 51284715 Tiamulin fumarate is a Commodity code for a specific veterinary pharmaceutical active ingredient, but the recent state and local contract opportunities tagged under this code show minimal alignment with its nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC for human-use antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and Seminole County, Florida released a competitive bid for Naloxone and drug deactivation systems—neither of which involves tiamulin fumarate or veterinary pharmaceuticals. The code shows little relevant recent activity for business development purposes.

State and local procurement offices are not currently sourcing tiamulin fumarate or related veterinary pharmaceuticals under this code at a scale or frequency that would support a pursuit strategy. The two posted opportunities misclassified under this code represent human pharmaceutical supply and opioid-reversal procurement, domains disconnected from the code's intended commodity. Monitor for future state and local veterinary health, agricultural, or animal-control initiatives that might correctly deploy this code, but treat current activity under 51284715 as noise rather than a market signal.